Quadrant Biosciences has received an Emergency Use Authorization (EUA) from the FDA for the Clarifi COVID-19 Test Kit by SUNY Upstate Medical and Quadrant Biosciences, a saliva-based test to detect nucleic acid from the SARS-CoV-2 virus.

The Clarifi COVID-19 Test, developed in partnership with SUNY Upstate Medical University,  leverages Quadrant Biosciences’ established expertise in RNA-based diagnostics. The non-invasive, and easy to administer, saliva swab test determines the presence or absence of SARS-CoV-2 viral RNA. The Clarifi COVID-19 Test contains a saliva collection swab and the reagents needed to run the analysis, and will be immediately available for use by high-complexity clinical laboratories serving patients through physicians’ offices, urgent care clinics and hospitals.

Quadrant Biosciences Press Release

Governor Cuomo’s Press Release

Wastewater surveillance

Our company, in collaboration with Syracuse University, SUNY Upstate Medical University, SUNY College of Environmental and Forestry, and global engineering firm Arcadis, is analyzing wastewater across New York State for the COVID-19 virus. 

Wastewater surveillance acts as an early warning system for COVID-19 by detecting the presence of viral RNA shed into the sewer systems. Our analysis of wastewater samples will provide local health officials and policymakers with early indications and information regarding the presence and preponderance of COVID-19 infections in these communities.

Click on these links to recent press about this collaborative project:

60 minutes story

Governor Cuomo’s Press Release